{"id":5880,"date":"2024-04-25T12:18:04","date_gmt":"2024-04-25T16:18:04","guid":{"rendered":"https:\/\/neoaptamers.com\/?p=5880"},"modified":"2026-04-13T10:58:01","modified_gmt":"2026-04-13T14:58:01","slug":"the-neoventures-business-strategy-part-2","status":"publish","type":"post","link":"https:\/\/neoaptamers.com\/fr\/the-neoventures-business-strategy-part-2\/","title":{"rendered":"The NeoVentures\u2019 Business Strategy Part 2"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5880\" class=\"elementor elementor-5880\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-2b722055 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"2b722055\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-606b5cfa\" data-id=\"606b5cfa\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6d8aed53 elementor-widget elementor-widget-text-editor\" data-id=\"6d8aed53\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Welcome to NeoVentures&#8217; Business Strategy Part 2. If you missed Part 1 check it out <a href=\"https:\/\/neoaptamers.com\/fr\/the-future-of-aptamers-in-diagnostics-part-1\/\">here<\/a>.<\/p><p>Keys to solving problems with aptamers:\u00a0<\/p><h3>Obtain good specific aptamers<\/h3><p>We think that the only way to reliably obtain aptamers that will be specific enough for commercial applications is to use our reinvented <a href=\"https:\/\/neoaptamers.com\/fr\/neomers-approach\/\">Neomer library<\/a> approach.<\/p><h3>Aptamer quality should be based on scientifically stringent binding assays<\/h3><p>Without binding assays there is no control that the aptamers have been well selected well. For our project, we use three types of binding assays in our lab.<\/p><ul><li>For small molecule targets, we use Isothermal titration calorimetry.<\/li><li>For Larger molecules targets, we use Surface plasmon resonance imaging.<\/li><li>For Cells as targets we use qPCR quantification of bound aptamers.<\/li><\/ul><h3>Perform selection on all relevant counter targets<\/h3><p>Our Neomer library approach allows us to apply the same initial na\u00efve library to different targets. This means that we already have a sequence database against common counter targets like HSA and IgGs. We explore counter targets extensively for each project, and we include everything that is relevant. It is important to eliminate cross-reactivity during selection because it may not fixable afterwards.<\/p><h3>Predict secondary structures of aptamers and truncate to optimize<\/h3><p>This strategy has been applied extensively by others. It involves predicting the secondary structure of the aptamer and then truncating the primer recognition regions. We believe that a shorter aptamer is still an aptamer. At NeoVentures we do extensive analysis of predicted secondary structure, create a hypotheses for functional structural motifs and test these hypotheses with a second round of binding assays.We include this analysis as part of a project. Aptamers work primarily because of their structure. Removing unnecessary elements and reducing structural flux through analysis of their energy landscape leads to aptamers with higher binding affinity and specificity. We will soon unveil an even deeper approach to structural analysis.<\/p><h3 style=\"font-size: 24px; font-weight: 600; font-family: Poppins, Arial, Helvetica, sans-serif; color: #2b2b2b; line-height: 38.4px; letter-spacing: normal; text-transform: none;\">Conclusion of NeoVentures&#8217; Business Strategy Part 2.<\/h3><p>As co-entrepreneurs we approach each project as a business opportunity. If we do not think that an aptamer will provide a feasible solution, we do not enter into the opportunity. Once we have entered into an opportunity, we are committed to making it work. When we encounter unexpected problems, we talk with you and we try to provide creative solutions. We do not always succeed, but we will definitely try. This is why we do not consider ourselves as a CRO. We do not consider a project is a success just because it is finished, we consider it as a success because we have succeeded in solving the problem.<\/p><p>Our passion and commitment to being co-entrepreneurs has driven our innovation to reinvent aptamer science. It would probably be easier if we were a CRO, but it is simply not in in our DNA. Our creativity is not driven by what is needed for aptamers to be commercially successful We need to share the problem and share the responsibility of solving it.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Welcome to NeoVentures&#8217; Business Strategy Part 2. If you missed Part 1 check it out here. Keys to solving problems with aptamers:\u00a0 Obtain good specific aptamers We think that the only way to reliably obtain aptamers that will be specific enough for commercial applications is to use our reinvented Neomer library approach. Aptamer quality should&hellip;&nbsp;<a href=\"https:\/\/neoaptamers.com\/fr\/the-neoventures-business-strategy-part-2\/\" rel=\"bookmark\">Lire la suite &raquo;<span class=\"screen-reader-text\">The NeoVentures\u2019 Business Strategy Part 2<\/span><\/a><\/p>","protected":false},"author":2,"featured_media":5881,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[42],"tags":[],"class_list":["post-5880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-about-neoventures"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The NeoVentures\u2019 Business Strategy Part 2 | Neoaptamers.com<\/title>\n<meta name=\"description\" content=\"Discover our unique Neomer approach, rigorous binding assays, and secondary structure optimization at NeoVentures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neoaptamers.com\/fr\/the-neoventures-business-strategy-part-2\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The NeoVentures\u2019 Business Strategy Part 2 | Neoaptamers.com\" \/>\n<meta property=\"og:description\" content=\"Discover our unique Neomer approach, rigorous binding assays, and secondary structure optimization at NeoVentures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neoaptamers.com\/fr\/the-neoventures-business-strategy-part-2\/\" \/>\n<meta property=\"og:site_name\" content=\"neoaptamers\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-25T16:18:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-13T14:58:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/04\/light-bulbs-1125016_1280.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gregory Penner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gregory Penner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/\"},\"author\":{\"name\":\"Gregory Penner\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\"},\"headline\":\"The NeoVentures\u2019 Business Strategy Part 2\",\"datePublished\":\"2024-04-25T16:18:04+00:00\",\"dateModified\":\"2026-04-13T14:58:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/\"},\"wordCount\":490,\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/light-bulbs-1125016_1280.jpg\",\"articleSection\":[\"About NeoVentures\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/\",\"name\":\"The NeoVentures\u2019 Business Strategy Part 2 | Neoaptamers.com\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/light-bulbs-1125016_1280.jpg\",\"datePublished\":\"2024-04-25T16:18:04+00:00\",\"dateModified\":\"2026-04-13T14:58:01+00:00\",\"description\":\"Discover our unique Neomer approach, rigorous binding assays, and secondary structure optimization at NeoVentures.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/light-bulbs-1125016_1280.jpg\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/light-bulbs-1125016_1280.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/the-neoventures-business-strategy-part-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neoaptamers.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The NeoVentures\u2019 Business Strategy Part 2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#website\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"name\":\"Neoaptamers.com\",\"description\":\"Neoventures Biotechnology Inc.\",\"publisher\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/neoaptamers.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#organization\",\"name\":\"NeoVentures Biotechnology Inc.\",\"alternateName\":\"NVB\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"contentUrl\":\"https:\\\/\\\/neoaptamers.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png\",\"width\":500,\"height\":500,\"caption\":\"NeoVentures Biotechnology Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neoventures-biotechnology-inc-\\\/\",\"https:\\\/\\\/www.reddit.com\\\/user\\\/NeoVenturesBiotech\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@neoaptamers7964\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/neoaptamers.com\\\/#\\\/schema\\\/person\\\/641d6a3e016e13414b8d0d0ffd5847ad\",\"name\":\"Gregory Penner\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g\",\"caption\":\"Gregory Penner\"},\"description\":\"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The NeoVentures\u2019 Business Strategy Part 2 | Neoaptamers.com","description":"Discover our unique Neomer approach, rigorous binding assays, and secondary structure optimization at NeoVentures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neoaptamers.com\/fr\/the-neoventures-business-strategy-part-2\/","og_locale":"fr_FR","og_type":"article","og_title":"The NeoVentures\u2019 Business Strategy Part 2 | Neoaptamers.com","og_description":"Discover our unique Neomer approach, rigorous binding assays, and secondary structure optimization at NeoVentures.","og_url":"https:\/\/neoaptamers.com\/fr\/the-neoventures-business-strategy-part-2\/","og_site_name":"neoaptamers","article_published_time":"2024-04-25T16:18:04+00:00","article_modified_time":"2026-04-13T14:58:01+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/04\/light-bulbs-1125016_1280.jpg","type":"image\/jpeg"}],"author":"Gregory Penner","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gregory Penner","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#article","isPartOf":{"@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/"},"author":{"name":"Gregory Penner","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad"},"headline":"The NeoVentures\u2019 Business Strategy Part 2","datePublished":"2024-04-25T16:18:04+00:00","dateModified":"2026-04-13T14:58:01+00:00","mainEntityOfPage":{"@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/"},"wordCount":490,"publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"image":{"@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/04\/light-bulbs-1125016_1280.jpg","articleSection":["About NeoVentures"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/","url":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/","name":"The NeoVentures\u2019 Business Strategy Part 2 | Neoaptamers.com","isPartOf":{"@id":"https:\/\/neoaptamers.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#primaryimage"},"image":{"@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#primaryimage"},"thumbnailUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/04\/light-bulbs-1125016_1280.jpg","datePublished":"2024-04-25T16:18:04+00:00","dateModified":"2026-04-13T14:58:01+00:00","description":"Discover our unique Neomer approach, rigorous binding assays, and secondary structure optimization at NeoVentures.","breadcrumb":{"@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#primaryimage","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/04\/light-bulbs-1125016_1280.jpg","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/04\/light-bulbs-1125016_1280.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/neoaptamers.com\/the-neoventures-business-strategy-part-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neoaptamers.com\/"},{"@type":"ListItem","position":2,"name":"The NeoVentures\u2019 Business Strategy Part 2"}]},{"@type":"WebSite","@id":"https:\/\/neoaptamers.com\/#website","url":"https:\/\/neoaptamers.com\/","name":"Neoaptamers.com","description":"Neoventures Biotechnology Inc.","publisher":{"@id":"https:\/\/neoaptamers.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neoaptamers.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/neoaptamers.com\/#organization","name":"NeoVentures Biotechnology Inc.","alternateName":"NVB","url":"https:\/\/neoaptamers.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/","url":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","contentUrl":"https:\/\/neoaptamers.com\/wp-content\/uploads\/2024\/07\/NeoVentures-Biotechnology-Square-Logo-No-Text-1.png","width":500,"height":500,"caption":"NeoVentures Biotechnology Inc."},"image":{"@id":"https:\/\/neoaptamers.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neoventures-biotechnology-inc-\/","https:\/\/www.reddit.com\/user\/NeoVenturesBiotech\/","https:\/\/www.youtube.com\/@neoaptamers7964"]},{"@type":"Person","@id":"https:\/\/neoaptamers.com\/#\/schema\/person\/641d6a3e016e13414b8d0d0ffd5847ad","name":"Gregory Penner","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/de665d788f86991000373f8dc389e0f6dcbb9228ffc3b4920b098d16c7c491e8?s=96&d=mm&r=g","caption":"Gregory Penner"},"description":"Dr. Gregory Penner academic training was a blend of very practical plant breeding theory combined with molecular biology. He has used this blend of biology and mathematics to first develop and lead a cereal biotechnology research team with the government of Canada and subsequently as a global research leader with Monsanto Inc. He has been a thought leader in aptamer development globally for the last twenty years as CEO and President of NeoVentures. \u00a0He has led this company to financial stability without outside investment with an integrated approach to aptamer discovery and commercialization. In 2015, he co- founded a second company, NeoNeuro in Paris France, focused on an innovative approach to identify Aptamarkers for complex diseases. Connect with Dr. Penner on LinkedIn or for company updates, follow NeoVentures. Click here to get in touch with our team."}]}},"_links":{"self":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5880","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/comments?post=5880"}],"version-history":[{"count":7,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5880\/revisions"}],"predecessor-version":[{"id":6483,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/posts\/5880\/revisions\/6483"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media\/5881"}],"wp:attachment":[{"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/media?parent=5880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/categories?post=5880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neoaptamers.com\/fr\/wp-json\/wp\/v2\/tags?post=5880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}